BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28046028)

  • 1. Predictive Value of Stemness Factor Sox2 in Gastric Cancer Is Associated with Tumor Location and Stage.
    Yang L; Xu JF; Kang Q; Li AQ; Jin P; Wang X; He YQ; Li N; Cheng T; Sheng JQ
    PLoS One; 2017; 12(1):e0169124. PubMed ID: 28046028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low P16
    Fu HC; Chuang IC; Yang YC; Chuang PC; Lin H; Ou YC; Chang Chien CC; Huang HS; Kang HY
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30150594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study.
    Chen XL; Chen XZ; Wang YG; He D; Lu ZH; Liu K; Zhang WH; Wang W; Li CC; Xue L; Zhao LY; Yang K; Liu JP; Zhou ZG; Hu JK; Mo XM
    Oncotarget; 2016 Sep; 7(38):62049-62069. PubMed ID: 27557490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis.
    Huang CF; Xu XR; Wu TF; Sun ZJ; Zhang WF
    J Oral Pathol Med; 2014 Aug; 43(7):492-8. PubMed ID: 24450601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALDH1A1 overexpression is associated with the progression and prognosis in gastric cancer.
    Li XS; Xu Q; Fu XY; Luo WS
    BMC Cancer; 2014 Sep; 14():705. PubMed ID: 25253129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX2, a predictor of survival in gastric cancer, inhibits cell proliferation and metastasis by regulating PTEN.
    Wang S; Tie J; Wang R; Hu F; Gao L; Wang W; Wang L; Li Z; Hu S; Tang S; Li M; Wang X; Nie Y; Wu K; Fan D
    Cancer Lett; 2015 Mar; 358(2):210-219. PubMed ID: 25543086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma.
    Matsuoka J; Yashiro M; Sakurai K; Kubo N; Tanaka H; Muguruma K; Sawada T; Ohira M; Hirakawa K
    J Surg Res; 2012 May; 174(1):130-5. PubMed ID: 21227461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased SOX2 expression in less differentiated breast carcinomas and their lymph node metastases.
    Huang YH; Luo MH; Ni YB; Tsang JY; Chan SK; Lui PC; Yu AM; Tan PH; Tse GM
    Histopathology; 2014 Mar; 64(4):494-503. PubMed ID: 24382260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of High Expression Levels of SOX2, NANOG, and OCT4 in Gastric Cancer Tumor Tissues with Progression and Poor Prognosis.
    Basati G; Mohammadpour H; Emami Razavi A
    J Gastrointest Cancer; 2020 Mar; 51(1):41-47. PubMed ID: 30628031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome.
    Camilo V; Barros R; Celestino R; Castro P; Vieira J; Teixeira MR; Carneiro F; Pinto-de-Sousa J; David L; Almeida R
    BMC Cancer; 2014 Oct; 14():753. PubMed ID: 25300947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
    Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C
    Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High ALDH1A1 expression indicates a poor prognosis in gastric neuroendocrine carcinoma.
    Ye Y; Zhang S; Chen Y; Wang X; Wang P
    Pathol Res Pract; 2018 Feb; 214(2):268-272. PubMed ID: 29103772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extra-capsular growth of lymph node metastasis correlates with poor prognosis and high SOX9 expression in gastric cancer.
    Link H; Angele M; Schüller M; Ganschow P; Machetanz L; Guba M; Werner J; Kirchner T; Neumann J
    BMC Cancer; 2018 Apr; 18(1):483. PubMed ID: 29703178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MALAT1 increases the stemness of gastric cancer cells via enhancing SOX2 mRNA stability.
    Xiao Y; Pan J; Geng Q; Wang G
    FEBS Open Bio; 2019 Jul; 9(7):1212-1222. PubMed ID: 31037832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aurora-A as an independent molecular prognostic marker in gastric cancer.
    Wang J; Yang S; Zhang H; Song Y; Zhang X; Qian H; Han X; Shi Y
    Oncol Rep; 2011 Jul; 26(1):23-32. PubMed ID: 21479365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of Sox2 expression in digestive tract cancers: A meta-analysis.
    Du XM; Wang LH; Chen XW; Li YX; Li YC; Cao YW
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):305-312. PubMed ID: 27376796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems.
    Allgayer H; Babic R; Gruetzner KU; Tarabichi A; Schildberg FW; Heiss MM
    J Clin Oncol; 2000 Jun; 18(11):2201-9. PubMed ID: 10829039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
    Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS
    World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
    Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
    J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.